Future Development genetics

Taking into account its much smaller size, the agrochemical industry has been more innovative than its pharmaceutical counterpart. Ten to twelve NMEs have been launched by the agrochemical industry each year during the past 25 years. The future development of demand for agrochemicals will depend primarily on the fate of genetically modified crops. The question as to whether they will be generally accepted for human nutrition by the public... 

But it is the n-hybrid assays that have the potential to extend the power of genetics to molecules other than proteins, such as nucleic acids and small molecules. Despite this enormous potential, use of these other n-hybrid assays pales in comparison to that of the two-hybrid assay. As we argue in this chapter, a consideration of the published literature suggests that this discrepancy is not the result of some inherent technical limitation to the n-hybrid assays, but rather likely reflects the bias of current practice. Thus, it is here that we believe there is most potential for the future development of the n-hybrid assay and indeed genetics as a whole. Technically, the n-hybrid assays probably still can be further developed for different classes of molecules or posttranslational modifications. But already in their present form these assays seem to have tremendous potential for biological discovery, uncovering new functions for the many classes of molecules that make up the cell. 

---